FTAI Aviation Ltd vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? FTAI Aviation Ltd trades at $162 (market cap $17.14B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: FTAI Aviation Ltd is the larger of the two by market cap, and FTAI Aviation Ltd pays the higher dividend (1.2%). Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 24 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| FTAI | RDY | |
|---|---|---|
Market Cap | $17.14B | $10.78B |
Volume | 3,282,791 | 2,724,343 |
Sector | Industrials | Health |
52-Week High | $310.04 | $15.38 |
52-Week Low | $152.80 | $11.38 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $20.25B | $10.68B |
Dividend Yield | 1.2% | 0.65% |
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $166.87, up 0.81% today, but technical indicators signal a bearish trend with key support at $163 and resistance at $169. The company reported strong 2025 revenue of $2.51 billion and net income of $501 million, though recent quarters have missed EPS expectations. Recent developments include a $500 million share buyback program and a strategic acquisition of 27 Boeing 737-700 aircraft, highlighting growth initiatives in aerospace services.
The outlook is mixed: analyst consensus is unanimously bullish with a $321.25 price target, but risks include volatile cash flows and competitive pressures. Upside potential hinges on execution of the buyback and aerospace segment growth, while earnings misses and negative operating cash flow pose near-term challenges for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →